According to Google, this system not only consistently reaches expert levels but often surpasses human capabilities. In ...

Generative AI often performs exceptionally well in controlled experimental environments, but its performance can significantly diminish in production settings due to differences in datasets, users, ...

Tempus AI's Tempus Pixel received FDA clearance for cardiac imaging updates, adding T1/T2 maps to enhance MR image analysis ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced ...

So, select any cell in your formatted Excel table, and in the Insert Tab on the ribbon, click the top half of the split ...

Bankruptcy prediction has traditionally relied on statistical approaches such as Altman’s Z-score, which use financial ratios ...

Twelve laboratories around the world have joined forces to map neuronal activity in a mouse’s brain as it makes decisions.

We present an integrated approach to derive multimodal MRI markers of cognition that can be transdiagnostically linked to psychopathology. This demonstrates that the predictive ability of neural ...

After more than three decades associated with or directly employed by NASA, Steve Platnick stepped down effective August 8, 2025. Steve began ...

Successful generative AI implementation in life sciences demands careful prioritisation and setting realistic expectations.

Investing.com -- Tempus AI, Inc. (NASDAQ:TEM) stock surged 16% Thursday morning following the company’s announcement that it received 510 (k) clearance from the U.S. Food and Drug Administration for ...

Alkermes plc (Nasdaq: ALKS) today announced detailed positive results from the Vibrance-1 phase 2 study evaluating alixorexton in patients with narcolepsy type 1 (NT1). Alixorexton, formerly ALKS 2680 ...